Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis
- Status
- WITHDRAWN
- Phase
- NA
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Desensitization in Kidney Transplantation
- Status
- COMPLETED
- Phase
- PHASE4
Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
- Status
- COMPLETED
- Phase
- PHASE2
Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE2
GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Bendamustine Hydrochloride in Combination With Rituximab in Patients With Relapsed Refractory Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment
- Status
- WITHDRAWN
- Phase
- PHASE2
Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study
- Status
- COMPLETED
- Phase
- PHASE3
Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders
- Status
- TERMINATED
- Phase
- PHASE2
Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2